Pharmacogenetic and Pharmacokinetics of Naproxen and Associated Naproxen-esomeprazole

NCT03092193 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant
Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant

Interventions

DRUG: Naproxen
DRUG: Naproxen-esomeprazole

Sponsor

University of Sao Paulo

Collaborators

[object Object]